Suppressing glutamate dehydrogenase guides hematopoietic stem cell divisions into self-renewal
Abstract Hematopoietic stem cells (HSCs) self-renew to expand their pool but often differentiate upon division. Thus, it remains unclear how HSCs maintain their stemness during or after division. Here, we show that the suppression of glutamate dehydrogenase (Glud1), a key enzyme responsible for glutamate (Glu) catabolism, supports the maintenance of HSCs during division. We find that self-renewing mouse HSCs during hematopoietic regeneration exhibited lower intracellular Glu levels compared to HSCs differentiating during ex vivo culture. We therefore focus on the negative regulation of Glu catabolic reactions as a candidate factor to maintain HSCs during division, and find that treatment with the Glud1 inhibitor, R162, maintains a subset of HSCs that would otherwise differentiate during division under normal culture conditions. This treatment successfully results in an approximately 500-fold expansion of functional mouse HSCs that maintain expression pattern of conventional stem cell markers over a 30-day culture period. Importantly, this positive effect of Glud1 inhibition is independent of suppressing cell divisions and dependent on robust JAK2-STAT signaling. Overall, our findings propose that Glud1 inhibition, coupled with robust JAK2–STAT signaling, characterizes a functional HSC state during division, enabling ex vivo expansion of mouse HSCs under conventional culture conditions.
Authors
- Terumasa Umemoto (ORCID: https://orcid.org/0000-0003-0423-9003)
- Yuichiro Arima (ORCID: https://orcid.org/0000-0002-9840-3347)
- Goro Sashida (ORCID: https://orcid.org/0000-0003-2318-5987)
- Hiroki Kurihara (ORCID: https://orcid.org/0000-0002-6476-5593)
- Toshio Suda (ORCID: https://orcid.org/0000-0001-7540-1771)
- Ayano Yahagi
- Akiyasu Iwase (ORCID: https://orcid.org/0000-0001-9095-5879)
- Michihiro Hashimoto (ORCID: https://orcid.org/0000-0003-1673-3340)
- Ayako Nakamura‐Ishizu (ORCID: https://orcid.org/0000-0002-5187-7553)
- Tomomasa Yokomizo (ORCID: https://orcid.org/0000-0001-6157-2852)
- Michie Uchikawa
- Kenichi Miharada (ORCID: https://orcid.org/0000-0001-8073-4001)
- Mizuki Ishimaru
- Yosuke Tanaka (ORCID: https://orcid.org/0000-0002-8538-0916)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Kaketsuken (Japan) (JP)
- Tokyo Women's Medical University (JP)
- Institute of Hematology & Blood Diseases Hospital (CN)
- The University of Tokyo (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-09-05
- DOI
- https://doi.org/10.1038/s41467-026-77151-6
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- Takeda Medical Research Foundation
- SENSHIN Medical Research Foundation
- Terumo Foundation for Life Sciences and Arts
- Princess Takamatsu Cancer Research Fund
- Japan Society for the Promotion of Science